13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001085146-25-005127
Total Value
$346.2M
Positions
15
Other Managers
1
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 1,568,841 | $82.5M | 23.84% |
| 2 | GH RESEARCH PLC | GHRS | 6,746,951 | $82.2M | 23.76% |
| 3 | STOKE THERAPEUTICS INC | STOK | 5,404,674 | $61.3M | 17.72% |
| 4 | PROTAGONIST THERAPEUTICS INC | PTGX | 733,014 | $40.5M | 11.70% |
| 5 | CULLINAN THERAPEUTICS INC | CGEM | 4,400,842 | $33.1M | 9.57% |
| 6 | ALLOGENE THERAPEUTICS INC | ALLO | 11,057,009 | $12.5M | 3.61% |
| 7 | TSCAN THERAPEUTICS INC | TCRX | 7,857,347 | $11.4M | 3.29% |
| 8 | C4 THERAPEUTICS INC | CCCC | 7,098,133 | $10.2M | 2.93% |
| 9 | PRECISION BIOSCIENCES INC | DTIL | 1,036,051 | $4.4M | 1.26% |
| 10 | PASSAGE BIO INC | PASG | 9,256,953 | $3.7M | 1.07% |
| 11 | UPSTREAM BIO INC | UPB | 219,247 | $2.4M | 0.70% |
| 12 | IBIO INC | IBIO | 1,538,573 | $1.2M | 0.34% |
| 13 | NEUPHORIA THERAPEUTICS INC | NEUP | 45,806 | $325,223 | 0.09% |
| 14 | DESIGN THERAPEUTICS INC | DSGN | 65,954 | $222,265 | 0.06% |
| 15 | ASSEMBLY BIOSCIENCES INC | ASMB | 10,366 | $187,832 | 0.05% |